Premier, Inc. (PINC)
NASDAQ: PINC · Real-Time Price · USD
24.53
+0.50 (2.10%)
Aug 13, 2025, 4:00 PM - Market closed
Premier Market Cap
Premier has a market cap or net worth of $2.02 billion as of August 14, 2025. Its market cap has decreased by -7.60% in one year.
Market Cap
2.02B
Enterprise Value
2.24B
1-Year Change
-7.60%
Ranking
Category
Stock Price
$24.53
Market Cap Chart
Since September 26, 2013, Premier's market cap has decreased from $4.31B to $2.02B, a decrease of -53.19%. That is a compound annual growth rate of -6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.02B | -0.86% |
| Dec 31, 2024 | 2.04B | -23.86% |
| Dec 29, 2023 | 2.68B | -35.59% |
| Dec 30, 2022 | 4.15B | -17.20% |
| Dec 31, 2021 | 5.02B | 17.06% |
| Dec 31, 2020 | 4.29B | -7.28% |
| Dec 31, 2019 | 4.62B | -7.19% |
| Dec 31, 2018 | 4.98B | 22.26% |
| Dec 29, 2017 | 4.07B | -4.06% |
| Dec 30, 2016 | 4.25B | -16.26% |
| Dec 31, 2015 | 5.07B | 4.82% |
| Dec 31, 2014 | 4.84B | -9.24% |
| Dec 31, 2013 | 5.33B | 23.53% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.24B |
| Johnson & Johnson | 418.67B |
| AbbVie | 355.26B |
| UnitedHealth Group | 243.78B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.32B |
| Novo Nordisk | 223.00B |